慢性心力衰竭的老年患者的自我管理任务表现及其与生物标志物的关联:横截面分析
Haixiang Zhu1, Xiaoxue Han1, Jinxuan Chen1
1Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
Patient preference and adherence
|September 15, 2025
概括
老年心力衰竭患者的自我管理不良与较高的NT-proBNP和尿酸水平有关. 提高自我护理技能,特别是药物管理,对于慢性心力衰竭 (CHF) 的更好的结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 生物标志物 生物标志物
背景情况:
- 老年人的慢性心力衰竭 (CHF) 管理需要有效的自我护理.
- 像NT-proBNP和尿酸这样的生物标志物可以反映CHF的疾病严重程度.
研究的目的:
- 研究老年CHF患者的自我管理任务表现和心力衰竭生物标志物 (NT-proBNP,尿酸) 之间的关系.
- 探索疾病严重程度在这种关联中的调解作用.
主要方法:
- 对103名老年CHF患者进行横截面研究.
- 自主管理任务的绩效使用六项任务级别进行评估.
- 分析包括部分相关性,逻辑回归和受限立方线分析.
主要成果:
- 较低的自我管理任务性能与较高的NT-proBNP和尿酸水平相关.
- 较高的表现与年轻的年龄和较低的生物标志物水平有关.
- 药物任务的成功率最低;胀和饮食任务的成功率更高.
结论:
- 老年CHF患者的自我管理能力下降与NT-proBNP和尿酸的升高有关,这表明疾病已经晚了.
- 针对自我管理的干预措施,特别是药物坚持,对于改善患者的治疗结果至关重要.
- 需要进一步研究提高自我管理技能的长期影响.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
541
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
Heart Failure VII: Nursing Interventions
422
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
422
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Cardiomyopathy VI: Nursing Management
314
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
314
Heart Failure IV: Classification and Diagnostic Evaluation
323
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261


